{"transactions":[{"id":1658665,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:54:25.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":437800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":437800,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":437800},"source":{"system":"sec-edgar","filing":"0001447028-24-000026","document":"wk-form4_1707180851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000026/wk-form4_1707180851.xml","form_type":"4"}},{"id":1658664,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:25.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":9982,"price":2.3125,"value":23083.375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 5, 2023,  to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units."}],"balance_after":1485121,"source":{"system":"sec-edgar","filing":"0001447028-24-000026","document":"wk-form4_1707180851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000026/wk-form4_1707180851.xml","form_type":"4"}},{"id":1658663,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:25.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":109500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1495103,"source":{"system":"sec-edgar","filing":"0001447028-24-000026","document":"wk-form4_1707180851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000026/wk-form4_1707180851.xml","form_type":"4"}},{"id":2032763,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:11:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":328700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":328700,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":328700},"source":{"system":"sec-edgar","filing":"0001447028-23-000010","document":"wf-form4_167545866810752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000010/wf-form4_167545866810752.xml","form_type":"4"}},{"id":2032762,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2023-02-03T21:11:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":82200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1385603,"source":{"system":"sec-edgar","filing":"0001447028-23-000010","document":"wf-form4_167545866810752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000010/wf-form4_167545866810752.xml","form_type":"4"}},{"id":2430303,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:54:28.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":285000,"price":2.81,"value":800850.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":285000,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001447028-22-000009","document":"wf-form4_164271925075900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000009/wf-form4_164271925075900.xml","form_type":"4"}},{"id":2485664,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2021-12-03T21:02:53.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":200000,"price":5.09,"value":1018000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021."}],"balance_after":1303403,"source":{"system":"sec-edgar","filing":"0001447028-21-000068","document":"wf-form4_163856535580377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000068/wf-form4_163856535580377.xml","form_type":"4"}},{"id":2854283,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2021-02-17T21:52:11.000Z","date":"2021-02-13","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":290000,"derivative":{"exercise_price":4.33,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001447028-21-000004","document":"wf-form4_161359869528005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000004/wf-form4_161359869528005.xml","form_type":"4"}},{"id":3262959,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2020-02-19T13:05:15.000Z","date":"2020-02-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":250000,"derivative":{"exercise_price":3.35,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001447028-20-000030","document":"wf-form4_158211749728222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000030/wf-form4_158211749728222.xml","form_type":"4"}},{"id":3612039,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-05T23:08:52.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in three equal annual installments beginning March 1, 2020."}],"balance_after":145000,"derivative":{"exercise_price":4.57,"expiration_date":"2029-03-01","underlying":"Common Shares","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001123292-19-000437","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000112329219000437/edgar.xml","form_type":"4"}},{"id":3843232,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-08-15T19:14:07.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":4250,"price":9.5143,"value":40435.775,"ownership":{"direct":false,"nature":"Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.5073 to $9.5525, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":167162,"source":{"system":"sec-edgar","filing":"0001567619-18-001171","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000156761918001171/doc1.xml","form_type":"4/A","original_submission_date":"2018-08-14"}},{"id":3844676,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-08-14T22:23:21.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":4250,"price":9.5143,"value":40435.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.5073 to $9.5525, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":1499153,"source":{"system":"sec-edgar","filing":"0001567619-18-001148","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000156761918001148/doc1.xml","form_type":"4"}},{"id":3867975,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-07-13T17:36:51.000Z","date":"2018-07-11","kind":"sale","acquired":false,"shares":10000,"price":10,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":1503403,"source":{"system":"sec-edgar","filing":"0001140361-18-032341","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118032341/doc1.xml","form_type":"4"}},{"id":3870249,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-07-10T17:11:55.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":10000,"price":8.906,"value":89060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $8.50 to $9.35, inclusive.  The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the rages set forth in this footnote."}],"balance_after":1513403,"source":{"system":"sec-edgar","filing":"0001140361-18-032008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118032008/doc1.xml","form_type":"4"}},{"id":3870248,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-07-10T17:11:55.000Z","date":"2018-07-06","kind":"sale","acquired":false,"shares":10000,"price":8.45,"value":84500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":1523403,"source":{"system":"sec-edgar","filing":"0001140361-18-032008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118032008/doc1.xml","form_type":"4"}},{"id":3871753,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-07-06T20:05:02.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":10000,"price":8.4,"value":84000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":1533403,"source":{"system":"sec-edgar","filing":"0001140361-18-031775","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118031775/doc1.xml","form_type":"4"}},{"id":3871752,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2018-07-06T20:05:02.000Z","date":"2018-07-03","kind":"sale","acquired":false,"shares":10000,"price":8,"value":80000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":1543403,"source":{"system":"sec-edgar","filing":"0001140361-18-031775","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118031775/doc1.xml","form_type":"4"}},{"id":3961009,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-18T18:25:51.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on April 16, 2019; 1/3 on April 16, 2020; and 1/3 on April 16, 2021."}],"balance_after":160000,"derivative":{"exercise_price":5.2,"expiration_date":"2028-04-16","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001140361-18-018906","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118018906/doc1.xml","form_type":"4"}},{"id":4190979,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2017-10-05T22:34:25.000Z","date":"2017-10-03","kind":"sale","acquired":false,"shares":10000,"price":8,"value":80000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":1553403,"source":{"system":"sec-edgar","filing":"0001140361-17-037745","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036117037745/doc1.xml","form_type":"4"}},{"id":4230683,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2017-08-17T23:41:37.000Z","date":"2017-08-15","kind":"sale","acquired":false,"shares":20000,"price":3.675,"value":73500.0,"ownership":{"direct":false,"nature":"Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the \"Trust\")."},"balance_after":171412,"source":{"system":"sec-edgar","filing":"0001140361-17-032651","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036117032651/doc1.xml","form_type":"4"}},{"id":4230682,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2017-08-17T23:41:37.000Z","date":"2017-08-15","kind":"sale","acquired":false,"shares":10000,"price":3.75,"value":37500.0,"ownership":{"direct":false,"nature":"Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the \"Trust\")."},"balance_after":191412,"source":{"system":"sec-edgar","filing":"0001140361-17-032651","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036117032651/doc1.xml","form_type":"4"}},{"id":4358139,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":94608,"kind":"person","name":"Sofia Michael J.","position":1,"cik":"0001635324","reported_name":"Sofia Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-05T19:44:32.000Z","date":"2017-03-24","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020."}],"balance_after":150000,"derivative":{"exercise_price":3.15,"expiration_date":"2027-03-24","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-17-014885","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036117014885/doc1.xml","form_type":"4"}}]}